The implementation of Regulation 396/2005 brought the benefit of harmonised MRLs throughout the European Union (EU) which addressed trade barriers not only with countries outside the EU but also those within the EU.  There have between continual changes including the development of  a number of annexes e.g. specifying compounds that are exempt from MRLs and processing factors, which give a transparent and harmonised approach throughout this region of the world.  There has been a positive movement towards the rapid acceptance and implementation of Codex MRLs into this legislation.  The next phase of the Regulation will be implemented in the near future addressing a number of areas such as cumulative risk assessment. However, along with all of these benefits, there has been a continual movement towards more rigorous assessments particularly relating to assessment of the consumer risk from metabolites which has resulted in some very complex residues definitions.  We will present an overview of the development of this legislation, a consideration of the next stages of its implementation and discuss both this benefits and the challenges that this legislation has brought.

Harmonisation and subsequent developments of maximum residues level (MRL) legislation in the European Union

248th National Meeting (2014)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.